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Abstract: 
The increasing occurrence of hospital infections and the emerging problems 
posed by antibiotic resistant strains contribute to escalating treatment 
costs. Inf ction on the wound site can potentially stall the healing process 
at the inflammatory stage, leading to the development of acute wounds. 
Traditional wound treatment regime can no longer cope with the 
complications posed by antibiotic resistant strains; hence there is a need to 
explore the use of alternative antimicrobial agents. In recent research, pre-
antibiotic compounds, including heavy metal ions and essential oils have 
been re-investigated for their potential use as effective antimicrobial 
agents. Essential oils have been identified to have potent antimicrobial, 
antifungal, antiviral, anti-inflammatory, anti-oxidant and other beneficial 
therapeutic properties. Similarly, heavy metal ions have also been used as 
disinfecting agents due to their broad spectrum activities. Such activities is 
contributed by reactive properties of the metal cations, which allows the 
ions to interact with many different intracellular compounds, thereby 
resulting in the disruption of vital cell function leading to cell death. This 
review will discuss the potential properties of essential oils and heavy 
metal ions, in particular tea tree oil and silver ions as alternative 









The increasing occurrence of hospital acquired infections and the emerging 
problems posed by antibiotic resistant microbial strains have both contributed to the 
escalating cost of treatment. The presence of infection at the wound site can 
potentially stall the healing process at the inflammatory stage, leading to the 
development of a chronic wound. Traditional wound treatment regimes can no longer 
cope with the complications posed by antibiotic resistant strains; hence there is a 
need to explore the use of alternative antimicrobial agents. Pre-antibiotic 
compounds, including heavy metal ions and essential oils have been re-investigated 
for their potential use as effective antimicrobial agents. Essential oils have potent 
antimicrobial, antifungal, antiviral, anti-inflammatory, anti-oxidant and other beneficial 
therapeutic properties. Similarly, heavy metal ions have also been used as 
disinfecting agents due to their broad spectrum activities. Both of these alternative 
antimicrobials interact with many different intracellular components, thereby resulting 
in the disruption of vital cell functions and eventually cell death. This review will 
discuss the application of essential oils and heavy metal ions, in particular tea tree oil 
and silver ions, as alternative antimicrobial agents for the treatment of chronic, 
infected wounds. 
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The use of metal ions and essential oils as antimicrobial agents is of particular 
interest in topical wound management. Management of chronic wounds such as 
varicose skin ulcers and burns aims to induce rapid healing and minimise the extent 
of scarring. Infection of such wounds can not only delay the healing process, but also 
lead to the development of chronic wound with increased potential to develop into 
systemic infection. Topical application of antimicrobial agents is common since 
effective concentrations may be difficult to achieve with systemic drugs as the effects 
of the wound trauma may impede delivery of the agent into the wound [1, 2]. The 
reduced concentration may also create selective pressure for antibiotic resistance. 
  
The current problems posed by increasing antibiotic resistance in  Gram-positive 
bacteria (methicillin resistant Staphylococcus aureus, MRSA, Vancomycin resistant 
enterococci, VRE) and Gram-negative bacteria (New Delhi metallo-β-lactamase-1, 
(NDM-1) positive Escherichia coli, multidrug-resistant Acinetobacter baumannii, 
ciprofloxacin-resistant  P. aeruginosa) [3, 4] have renewed interest in pre-antibiotic 
antibacterial agents such as metal ions and essential oil (TTO) [5, 6].  Alternative, 
non-antibiotic based treatments are attractive due to their decreased side effects 
compared to synthetic drugs, and their multiple target sites within the 
microorganisms, which may contribute to reduced development of resistant strains 
[7].  Despite their usefulness and long history of use, these agents are mainly 
restricted to topical applications against infected wounds, skin burns, ulcers and 
fungal infections of the skin. Despite their effectiveness in treating topical infections, 
the complete healing of wounds, especially slow/non-healing wounds, may require 
repeated application or use of high concentrations that may have adverse effects on 
the patient. Current developments in wound treatment focus on approaches that will 
allow reduced concentration (using combined agents) or delivery via controlled 




release delivery systems to minimise potential side effects whilst maintaining 
bioavailability to achieving therapeutic effects [8, 9, 10, 11]. 
  
The useful properties of alternative antimicrobial agents, together with advances in 
drug delivery technologies may be able to enhance and expand the medical 
applications of these agents [9, 10, 12]. Combining these alternative antimicrobial 
agents with advanced drug delivery systems aims to: 
• Promote bioavailability of agent at microbiocidal concentrations. 
• Reduce drug concentration to enhance safety and practicality of application. 
• Minimise scarring and promote wound healing processes. 
• Reduce discomfort and pain in consideration of the patients psychological needs. 
• Decrease the frequency of dr ssing changes. 
These aims would increase convenience, provide less opportunity for infection 
and/or reinfection of the wounds and ultimately reduce treatment costs. 
  
Microorganisms and wound management 
In healthy individuals, the skin supports a natural microflora comprising a balanced 
community of microorganisms, which rarely cause infection. However, a disturbance 
to the normal ratio of microflora or an exposure of subcutaneous tissue due to 
trauma may result in pathogenic invasion by these microorganisms [7]. Colonization 
of wounds by these opportunistic pathogens is usually polymicrobial [12]. The 
diversity and proliferation of the pathogens is influenced by various factors including, 
the type, depth, location of the trauma as well as the host immune system response 
[7]. The presence of microorganisms at a wound site does not confirm infection 
[13].  Infection only occurs when the host immune system can no longer cope with 
the virulence factors expressed by the colonizing microorganisms, thus triggering a 
series of systemic responses which delay the healing process [7, 13]. 





The increasing occurrence of hospital infections and widespread emergence of 
resistant microorganisms contribute to escalating treatment costs. Additionally, 
hypersensitivity reactions to antibiotics and the lack of access to new treatments 
within the health care industry, makes provision of sufficient support and care for 
patients difficult. Modern lifestyles which frequently lack physical activity increase the 
possibility of developing various life-long (interconnected) health 
conditions, e.g. diabetes, obesity and hypertension in old age. These underlying 
health conditions may influence the complexity and severity of wound healing. In 
addition, the growing size and longevity of the elderly population has increased the 
prevalence of wounds associated with these conditions, including slow/non-healing 
ulcers. The improvement in medical facilities has increased the number of patients 
surviving from complicated wounds, such as those caused by burns. Although rates 
of survival have improved, severely burned patients usually require extended stays 
in hospital, suffer from lowered immunity and extensive loss of skin. Such patients 
are prone to infection by both common ound pathogens as well as antibiotic 
resistant microorganisms, which may further complicate the treatment regime [1]. 
  
The nature of burn wounds and varicose ulcers in particular may involve relatively 
lengthy treatment with antibiotics which carries the attendant risk of selecting drug 
resistant bacteria.   Various approaches have been conducted to find the best 
method to treat and overcome this problem. The increasing incidence and 
broadening spectrum of pathogens resistant to antibiotics, has refocused scientific 
interest on the use of alternative antimicrobial compounds [6, 14]. Alternative, non-
antibiotic based treatments are attractive due to their decreased side effects 
compared to synthetic drugs, and their multiple target sites within the 
microorganisms, which may contribute to reduced development of resistant strains 
[7]. Despite their usefulness and long history of use, these agents are mainly 




restricted to topical applications against infected wounds, skin burns, ulcers and 
fungal infections of the skin. 
  
Microorganisms and the wound environment 
In healthy individuals, the skin supports a natural microflora comprising a balanced 
community of microorganisms, which rarely cause infection. However, a disturbance 
to the normal ratio of microflora or an exposure of subcutaneous tissue due to 
trauma may result in pathogenic polymicrobial invasion by these microorganisms [7]. 
The diversity and proliferation of the pathogens is influenced by various factors 
including, the type, depth, location of the trauma as well as the host immune system 
response [7]. The presence of microorganisms at a wound site does not confirm 
infection [13].  Infection only occurs when the host immune system can no longer 
cope with the virulence factors expressed by the colonizing microorganisms, thus 
triggering a series of systemic responses which delay the healing process [7, 13]. 
Besides patient microflora, other sources of infection include those acquired directly 
or indirectly via air, other infected patients, health care workers, contaminated 
medical devices, hospital environment and external sources e.g. visitors [15]. 
  
Cutaneous wounds offer a favourable (moist, warm, nutritious) environment to 
support bacterial growth and proliferation. Heavy microbial infection (above critical 
colonization) retards wound healing by increasing the bio-burden at wound sites, 
which stalls the normal process at the inflammatory phase. When acute wounds 
become infected and reach critical colonization by pathogenic microorganisms, the 
stimulated pro-inflammatory environment (due to microbial production of toxins, 
proteases or pro-inflammatory molecules), will stop the process of wound healing 
and the site develops into a chronic wound [7, 10, 12, 20]. 
  




Alternative antimicrobial agents 
Although conventional antibiotics are regarded as effective antimicrobial agents, 
there is concern about their side effects and the increasing incidence of microbial 
resistance to them [22].  Antimicrobial agents are only effective until resistant strains 
of the target microorganisms begin to emerge [6, 23]. With conventional antibiotics 
the emergence of resistance is mainly due to their action against a single target. This 
has led to re-examination of the use of other antimicrobial agents, such as metal ions 
and plant extracts, which often attack multiple target sites [6, 22, 24, 25]. 
  
The application of essential oils to reduce bacterial growth and prevent decay is not 
a new idea. Plants synthesize aromatic secondary metabolites to protect against 
predation and prevent colonization by plant pathogens [24]. These aromatic 
compounds are divided into classes including essential oils (primarily phenolics 
and/or terpenoids), alkaloids, lectins, polypeptides and polyacetylenes, all of which 
have different mechanisms of antimicrobial activity [24]. Some examples of essential 
oils or plant extracts commonly used for their antimicrobial properties are tea tree oil, 
ylang ylang, betel pepper, manuka, eucalyptus, arnica, lemon verbena, rosemary, 
green tea extract and cadendula [24, 23]. Although extensively practiced since 
ancient times, the use of natural extracts from plants as antimicrobial compounds 
declined after the development of synthetic antibiotics. 
  
Metals (especially heavy metals) were used as disinfecting agents since ancient 
times. Silver, copper and gold for example have been used to treat diseases, 
disinfect wounds and water. Examples of metals commonly used in these 
applications include zinc, iron, bismuth, cobalt, magnesium, titanium, copper and the 
more extensively used heavy metal, silver. Despite having useful properties, 
treatment using metals is limited because excessive concentration of metals, 
especially heavy metals are toxic to human cells. Amongst the heavy metals, silver 




has a long history of use as an antimicrobial agent due to its relatively lower toxicity 
to human cells [26, 27]. Recently in response to issues surrounding antibiotic 
resistance, topical application of silver compounds has increased in popularity [28]. 
  
Plant products as antimicrobial agent 
Plants with medicinal properties have been used for the treatment of various 
diseases both in traditional and modern. When faced with microbial invasion or 
attack leading to infection, plants have their own defence mechanisms which rely on 
the production of compounds which interfere with the cellular and intra-cellular 
structure of microorganisms [29]. These antimicrobial plant compounds which show 
effective antimicrobial activity are often secondary metabolites formed in aromatic 
plants. These aromatic compounds give the plants their characteristic strong odour 
[29], that can repel insects or herbivores. In addition, certain compounds give plants 
pigment or flavour; these may be irritant to other organisms, and may flow out from 
injured plants to prevent colonization by microorganisms [30, 31]. These secondary 
metabolites are mainly present as volatile compounds such as phenols or their 
oxygen-substituted derivatives, which are categorized into five major classes 
detailed in Table 1 [24]. All plant organs including buds, flowers, leaves, stems, 
seeds, fruits, twigs and branches are able to synthesize these compounds. 
  
The amount of active compound present in botanical extracts varies depending on 
the main adaptation of the plant to its environment, harvesting period, the extraction 
process, dehydration procedures, purification and storage methods [25]. The 
extraction of secondary metabolites from plants is usually by distillation (water or 
steam) to produce a volatile essential oil. Essential oils are aromatic compounds 
synthesized by plants as secondary metabolites and are well known for their 
antibacterial, antifungal and antiviral properties [6, 29], in addition to anticancer, anti-
diabetic, anti-inflammatory and anti-oxidant activities [29, 32]. Essential oils are 




multi-component compounds, usually with terpenes and their derivatives (terpeniods) 
as the major components. After extraction they present as clear, almost colourless 
volatile liquids, soluble in organic solvents and lipids in addition to some hydrophilic 
components [29]. Due to the versatility and wide ranging properties of essential oils, 
they are used not only in the pharmaceutical industry but also incorporated into the 
cosmetics, agriculture, sanitation, disinfection, food preservation and manufacturing 
industries [25, 29]. Examples of the various uses of essential oils are summarized in 
Table 2. 
  
Tea tree essential oil as an antimicrobial 
History, background of use and production of tea tree oil 
Bundjalung Aborigines of northern New South Wales traditionally used crushed tea 
tree leaves as a treatment for coughs and colds (inhalation), as a herbal infusion for 
sore throats and also sprinkled them directly onto skin wounds to promote healing 
[33]. The use of tea tree oil (TTO)  as an antimicrobial agent became a common 
practice after Penfold published reports on its antimicrobial properties in the 1920s 
and 1930s [33]. In modern society, the useful properties of TTO are made 
commercially available either as the essential oil per se, or alternatively formulated 
into various products including antiseptic creams, soaps, shampoo, anti-acne 
creams, toothpaste and household cleaning agents. 
  
TTO is recognised as having broad spectrum antibacterial, antifungal, antiviral, 
antimycoplasmal and antiprotozoal activity, as well as anti-inflammatory and anti-
cancer properties [33, 34]. There are over one hundred different components in 
whole TTO. There are over one hundred different components in whole TTO of 
which its major component, terpinen-4-ol, is primarily responsible for its active 
antimicrobial properties [33]. TTO is extracted from the leaves and terminal branches 
of the Melaleuca alternifolia plant via steam distillation, and condensed to yield a 




pale yellow oil [33]. Due to tThe potential variation in the composition of the TTO 
components, has lead to the classification of six chemotypes of Melaleuca 
alternifolia, has been described based on the amount of terpinen-4-ol (one type), 
terpinolene (one type) and 1,8-cineole (four types) [33]. Commercially acceptable 
grade of TTO are classed in the terpinen-4-ol chemotype and haves to comply with 
ISO4730:2004 standards for “Oil of Melaleuca, terpinen-4-ol type”, which defines the 
maximum and minimum level for the fourteen major components of the essential oil, 
including terpinen-4-ol [33]. 
  
Mode of action 
The physicochemical properties of the oil include those from hydrophilic hydrocarbon 
compounds with sufficient lipophilicity and allow the oil to partition preferentially into 
biological membranes causing bilayer expansion [33]. Thus TTO components diffuse 
easily through the hydrophobic lipid bilayer of the microbial cell membrane, causing 
disruption to integrity and function, increased fluidity, loss of permeability and 
inhibition of embedded membrane enzymes. Consequently the cell loses essential 
metabolites and repair enzymes, ultimately resulting in cell death [33, 35]. The 
microbiocidal properties of active monoterpenes in particular, can mainly be 
attributed to disruption of the cell membrane’s barrier function; cells are thus unable 
to establish control over membrane-coupled energy-transducing processes, solute 
transport, regulation of metabolism and maintenance of turgor pressure [35]. 
However when a compound is highly lipophilic, its low solubility in aqueous media 
hinders its ability to contact with and permeabilize cell membranes [36]. 
  
Cox et al. (2000) examined membrane disruption of E. coli, S. aureus and C. 
albicans by TTO via the leakage of potassium ions, materials that absorb at 280nm 
(proteins) and uptake of fluorescent nucleic acid stain, propidium iodide [35]. All 
three microorganisms showed decreased microbial viability (inhibition of respiration), 




increased uptake of propidium iodide and increased leakage of 280nm absorbing 
material. Leakage of potassium ions was prominent in E. coli and S. aureus but less 
so in C. albicans [35, 37]. Carson et al. (2002) assessed the release of 260 nm 
absorbing materials (nucleic acids) from S. aureus after treatment with whole tea 
tree oil, terpinen-4-ol, 1,8-cineole and α-terpineol [32]. These results showed 




Preparations containing TTO are commonly used as antiseptic agents with 
antimicrobial, cleansing, healing and itch relieving properties [39]. For example, 
creams containing 5% TTO have been used to treat acne and toenail 
onychomycosis. A 6% gel formulation was shown to have antiherpetic effects; and 
TTO has been used as an antiseptic agent in handwash soaps, mouthwashes, as 
well as for the treatment of microbial infections such as folliculitis and vaginitis [39, 
40, 41, 42, 43].  Whole TTO essential oil applied over 12 days successfully and 
permanently removed skin warts, whereas salicyclic acid (12% w/w) and lactic acid 
(4% w/w) only resulted in temporary removal of the warts [44]. Treatment with 4% 
TTO nasal ointment together with a 5% TTO body wash performed better at 
eradicating methicillin resistant S. aureus (MRSA) from patients than 2% mupirocin 
nasal ointment together with 2% triclosan body wash [45]. Similarly a 10% TTO 
cream and 5% TTO body wash was more effective at clearing MRSA on skin, 
compared to 4% chlorhexidine gluconate soap and 1% silver sulfadiazine cream 
[46]. In contrast, treatment of MRSA in the nasal cavity alone, even with 10% TTO 
cream, showed only 47% eradication [46]. 
  
TTO has been widely used in the management of wounds due to its antimicrobial 
and therapeutic properties. Burnaid® is a commercial hydrogel dressing impregnated 




with TTO for the treatment of burns [47]. Other studies have reported the 
enhancement of antimicrobial activity, when using TTO in combination with other 
antimicrobial agents such as chlorhexidine [8, 23], tobramycin [48] and silver ions 
[34]. 
  
Wound healing benefits 
In addition to antimicrobial activity, TTO also plays a role in wound healing and 
modulation of the inflammatory response [6, 49, 50].  Water soluble components of 
TTO, especially terpinen-4-ol, contribute to inflammatory regulation by suppressing 
monocyte production of superoxide ions [50], as well as inflammatory inducing 
mediators e.g. TNFα, IL-1β, IL-8, IL-10 and PGE2 [49]. This in turn limits further 
production of other inflammatory cytokines [49] and reduces oxidative damage to 
cells [6], thereby enhancing wound healing. 
 
The aromatic vapours and analgesic properties of TTO to may promote wound 
healing by providing temporary relief to patients [47, 51]. Burnaid®, reduces skin 
temperature at the burn site by approximately 2oC within 20 minutes, providing 
localized soothing and cooling effects [47], and may improve the patients’ ability to 
cope with the treatment. Using TTO to treat patients with malodorous skin ulcers, 
showed a significant reduction of the malodour as well as of infection and pus 
secretion [51, 52]. The TTO compounds therefore improved the patient’s wellbeing 
by reducing social isolation associated with the malodour. 
  
Resistance 
Despite the popularity of TTO in many applications, concerns of microorganisms 
developing resistance have not been totally neglected. In vitro exposure of S. 
aureus to stepwise increasing concentrations of TTO resulted in selection of TTO 
resistant sub-populations [53]. 





Although there is little evidence of cross-resistance to conventional antibiotic 
resistant strains with TTO [33], mutant strains of S. aureus with reduced 
susceptibility to household cleaning agents containing plant extracts, were less 
susceptible to TTO [54]. Based on the available data, the activity of TTO may not 
favour spontaneous development of resistance, however it is still important to 
minimise exposure to sublethal concentrations to limit the possibility of resistance 
development [33, 53]. 
  
TTO resistance is also noted in Gram-negative bacteria due to the nature of the 
outer membrane, which is composed of lipopolysaccharide, proteins and 
phospholipids. This membrane provides a hydrophilic permeability barrier which is 
an essential factor in the tolerance of P. aeruginosa to membrane damaging agents, 
such as TTO [36]. 
  
Toxicity concerns 
As with most drugs, overdose or extended exposure induces toxic side 
effects.  Evidence from several reports has shown that toxicity of TTO when ingested 
is rarely if ever fatal [33]. Generally, the symptoms of oral toxicity of TTO vary 
according to age and dose ingested. Reported symptoms arise from effects on the 
central nervous system resulting in changes in respiration rate, oxygen saturation 
levels, pupil reactivity, electrolyte and blood glucose concentration, development of 
systemic hypersensitivity, ataxia, muscle weakness, unconsciousness and 
hallucination [55, 56]. Similar toxic symptoms including lack of co-ordination, muscle 
tremors, dehydration, hypothermic, ataxic effects and in more severe cases, death 
have been observed in animals [57]. 
  




Dermal toxicity of TTO has been reported to cause irritation and allergic reactions 
[33]. The localized cooling effect on treated burn wound sites may lead to triggering 
hypothermia when using TTO-based dressings on large areas of the skin [47]. 
  
Heavy metals as antimicrobial agents 
Heavy metals have a density of at least 5 g/cm3 and are located centrally in the 
periodic table, along with all the other transition elements, due to their ability to form 
complexes via their partially filled d-orbitals [58]. These d-orbitals allow the heavy 
metals to accept electrons to form complexes, either by redox or other biochemical 
reactions in the cell. At low concentrations, some heavy metals may serve as 
essential trace elements to maintain normal cell function. However at high 
concentrations, cell toxicity may result from the formation of unspecified complexes 
within the cell [58, 59]. Three classes of heavy metals have been proposed by Nies, 
1999 [58]: 
i. low toxicity and play an important role as trace elements, e.g. iron (Fe), 
molybdate (Mo), manganese (Mn), 
ii. toxic but high to moderate importance as a trace element, e.g. zinc (Zn), 
nickel (Ni), copper (Cu), vanadium (V), cobalt (Co), tungsten (W), chromium 
(Cr); and 
iii. toxic with little or no beneficial action, e.g. arsenic (As), silver (Ag), antimony 
(Sb), cadmium (Cd), mercury (Hg), lead (Pb) and uranium (U). 
  
Amongst the various biological functions of heavy metals, their antimicrobial activity 
will be discussed in further detail. The sequence of antimicrobial toxicity is reported 
as follows:  Ag > Hg > Cu > Cd > Cr > Pb > Co > Au > Zn > Fe > Mn > Mo > Sn [60] 
The mechanism of antimicrobial action of heavy metal cations varies due to 
differences in chemical characteristics and their effect on different biochemical 




pathways in the cell (Table 3). These effects result in disruption of the 
microorganisms’ normal cell function leading to irreversible damage and cell death 
[58, 61]. 
  
Metal cations interact with ionisable intracellular groups such as carboxylates and 
phosphates in the lipopolysaccharide layer of Gram-negative bacterial cells, 
peptidoglycan and teichoic acids of Gram-positive bacterial cells [62].  Metal cations 
may get incorporated into the cell membrane, causing loss of fluidity, followed by 
further transport into the cell cytoplasm to inhibit vital biochemical processes hence 
disturbing the normal growth [58, 63]. This transport is usually achieved via an 
unspecified system utilising a chemiosmotic gradient between the cell and its 
environment or alternatively an ATP-dependant specific transport system [58, 61]. 
  
Within the cytoplasm, metal cations may affect various cell processes [62], for 
example, they may bind to sulfhydryl or thiol groups, leading to inhibition of various 
enzymes [58]. Some examples of toxic activities of metal cations towards 
microorganisms are detailed in table 3. 
            
Despite their usefulness as antimicrobial compounds, the intensity of exposure 
(duration and concentration applied) should be carefully considered. Cobalt, 
cadmium and mercury are too toxic to be used clinically as antimicrobial agents. 
Copper, zinc and silver are less toxic to human cells. These are often incorporated 
into antiseptic creams or cleaning agents, as well as surfaces of medical devices 
surfaces including hospital taps and door handles [64, 65]. Examples of applications 
using heavy metal ions and their mechanism of action are detailed in table 4. 
  




Silver as an antimicrobial 
History and background of the uses of silver 
The antimicrobial properties of silver, including its use as an active water disinfectant 
has been have been documented since 1000 B.C. [66]. The use of silver as an 
antimicrobial tool has been reported since ancient Greek and Roman periodstimes, 
in which silverware was used to store perishable food and drinks. By the 
19th century, the use of silver ions, Ag+ (as silver nitrate) in medical applications 
became more widespread with records of it being used to treat venereal diseases, 
salivary gland fistulae, bone and perianal abscesses, and removal of granulation 
tissue prior to epithelialisation [66, 67]. After the discovery of penicillin and the rapid 
expansion in the number and use of antibiotics [54, 66, 68] the antimicrobial use of 
silver declined. Recent widespread emergence of antibiotic resistant microorganisms 
has resulted in Ag+ based agents regaining popularity since their multi-target action 
in microbial cells is less likely to lead to silver resistance [60, 69]. 
  
Silver in its non-ionised form, is an inert metal that does not react with human cells 
[70]. Compared to other heavy metals, Ag+ have relatively low toxicity towards 
human cells at concentrations that are still highly effective against microbial 
pathogens [71, 72, 73]. 
  
The reactivity of Ag+ even at concentrations as low as 10-9 to 10-6 mol/L (equivalent 
to 0.000108-0.108 ppm), has shown broad spectrum antibacterial, antiviral, 
antiprotozoal and antifungal activity [74]. In addition, the antimicrobial activity and 
low toxicity of silver characteristics towards human cells of silver is also 
accompanied by wound healing properties [67]. Silver is able to treat infections whilst 
enhancing wound healing, which could be especially useful in the management of 
severe wounds such as burns and slow/non-healing ulcers. 
  




Mode of action 
Ag+ are classified as highly reactive moieties, which readily bind anions formed by 
electron donor groups containing sulphur (thiols), oxygen and nitrogen 
[74]. Ag+ demonstrate broad spectrum antimicrobial activity at concentrations as low 
as 0.05 ppm in phosphate buffered saline, or between >50 ppm to 60.5 ppm in 
complex organic biological fluids [5, 75, 76, 77].  Ag+ express their antimicrobial 
activity initially by binding to cell surface proteins and enzymes, resulting in 
morphological cellular changes, inhibition of cell replication [75, 78, 79] and 
impairment of solute and electron transport systems, leading to reduced production 
of vital cell components, such as ATP [80]. Subsequent uptake of Ag+ into the cell 
cytoplasm either via non-specific or substrate-specific transport systems, allow 
Ag+ to bind and interfere with the activity of essential intracellular enzymes and DNA 
[74, 78, 79]. 
  
In the presence of oxygen, Ag+ also promote the generation of reactive oxygen 
species through inhibition of respiratory enzymes, such as NADH 
dehydrogenase II [81] or by impairing superoxide-radical-scavenging enzymes such 
as superoxide dismutase [82].  Evidence also suggests that the antimicrobial activity 
of Ag+, may be a consequential result of their ability to bind to essential enzyme 
sulphydrals groups (thiols), thereby breaking these protein bonds [83]. The binding of 
Ag+ to anionic groups, most notably disulfide, amino, imidazole, carbonyl and 
phosphate residues results in intracellular and nuclear membrane (in eukaryotes) 
permeability changes, as well as structural modifications of the cell wall [79, 84, 85]. 
  
Ag+ may also binds to DNA bases, causing condensation and degenerative changes 
of DNA strands, leading to inhibition of cell replication and cell death [72, 79]. 
Generally the antimicrobial mechanism of action of Ag+ is described as a cascade of 
four steps [80]: 




• The Ag+ binds to receptors (especially in protein residues including sulphydryl, 
amino, imidazole, phosphate and carboxyl groups) on the microbial cell 
membrane, resulting in membrane damage.  
• After entering the cytoplasm, Ag+ bind to other essential enzymes, restricting 
their activity and the production vital metabolites. 
• Binding to microbial DNA follows, thereby impairing cell replication. 
• With weakened membrane structure and inhibition of cellular processes, vital 
components leak out, the bacterial cell cannot maintain normal function, resulting 
in cell death.  
 
Applications 
Formulations containing silver are commonly used to treat a variety of Gram-positive 
and Gram-negative bacteria, as well as common highly antibiotic resistant 
microorganisms such as P. aeruginosa [79, 86]. Silver based pharmaceutical 
preparation, for example silver sulfadiazine (Flamazine®) has been used for the 
treatment of burn wounds. It has been found that the antimicrobial activity of Ag+ 
depend not only on the amount of bioactive ions present, but also bioavailability 
which is influenced by the physical and chemical form of silver, the affinity for 
moisture, rate of release and distribution [74, 79, 84, 87]. 
 
In the skin, silver may form a temporary reservoir by binding to proteins with an 
estimated half-life of 10-12 hours [26]. Being a highly reactive species, Ag+ can 
readily bind to components present in the wound bed, for example negatively 
charged proteins, RNA, DNA and chloride ions [5], thereby limiting the bioavailability 
of the ions. This ‘quenching’ effect of the host tissues may lead to the need for the 
application of higher and potentially damaging doses of Ag+ for effective treatment. 
 
Recent advances in controlled delivery systems, which incorporate antimicrobial 
agents such as Ag+ into delivery devices or dressings, may play a role in overcoming 




the potential problems caused by the increased exposure and concentration of active 
antimicrobial agent. Some examples of silver containing wound dressings available 
for current wound management applications include DuoDERM® (hydrocolloids), 
Aquacel® Ag (hydrofibre dressings containing antimicrobial silver ions), 
TegadermTM (films), VaselineTM (gauze), Sorbsan® (alginates), Lyofoam® C (foam 
dressing) and Nu-GelTM (hydrogels) [16, 17]. 
 
Wound healing benefits 
As discussed above, Ag+ helps to promote wound healing by reducing the bacterial 
load at wound site. Ag+ can also enhance wound healing directly by modulating the 
inflammatory response [88]. At wound sites, Ag+ are taken into epithelial cells 
responsible for the regulation of tissue metal homeostasis, heavy metal detoxification 
and wound healing [5]. This uptake induces the synthesis of low molecular weight 
cysteine-rich metal-binding proteins called metallothioneins (metallothioneins I and 
II). This activity of metallothioneins, which protect the healthy cells from the toxic 
effects of metals, is induced by several other xenobiotic metals such as cadmium, 
gold and mercury [88]. Metallothioneins also play an important role in promoting the 
uptake of key trace elements, such as zinc and copper, promoting RNA and DNA 
synthesis, cell proliferation, epithelialisation and tissue repair [5, 88]. Rising zinc 
levels induced by the accumulation of Ag+ in wounds, increased the activity of the 
zinc metalloenzymes thus promoting cell proliferation and reepithelialisation in rats 
[88]. 
 
During wound repair and the inflammatory response, matrix metalloproteinases 
(MMPs) are present in within the wound. MMPs function to cause breakdown of the 
extracellular matrix, autolytic debridement, dissolution of basement membranes, 
growth promotion of capillary beds, reepithelialisation and tissue remodelling [72]. 
Hence MMPs are essential in wound healing, but excessive levels degrade 
fibronectin and peptide growth factors needed for optimal re-epithelialisation [5, 72]. 




Ag+ may form stable complexes with MMPs, thus down regulating excessive 
localized inflammatory response to promote wound healing [72, 88]. Comparative 
studies revealed that patients had improved epithelialisation on the skin grafts when 
treated with nanocrystalline silver dressings in comparison to topical antibiotics [85]. 
Research data have shownResults indicated that Acticoat™, a nanocrystalline silver 
containing product, was effective as a dressing which reduced the wound bioburden 
whilst and altereding the the process of inflammatory ion,events to thus facilitateing 
the healing process [85, 89]. The ability of Acticoat™ to provide prolonged sustained 
release of silver onto the wound site helps to avoid the development of resistance 
microorganisms whilst reducing potential toxic side effects [85, 89].  
 
Resistance 
While this multi-locus action of silver makes development of resistant 
microorganisms less likely, such resistance has been observed [8990] and with the 
increasing use of silver it may be a caus  for concern [68, 9091]. The occurrence of 
resistance genes have been reported and may be chromosomal or plasmid born 
[9192, 9293]. The identified silver resistance plasmid, pMG101, codes for 
periplasmic binding proteins (SilE and SilF) and a chemiosmotic efflux pump 
(SilCBA) which exports Ag+ donated from an ATPase efflux pump (SilP) via SilF 
[8990, 9192, 9293, 9394]. 
 
The initial mechanism of resistance may be due to periplasmic Ag+ binding proteins, 
SilE, each of which binds five Ag+ in the periplasmic space. Synthesis of SilE is 
stimulated by the presence of Ag+ during growth [8990]. Although SilE has high 
affinity for Ag+, the actual release mechanism of the bound Ag+ has yet to be 
determined. It is possible that the Ag+ may be released to the cell exterior via the 
SilCBA protein trimer. The SilCBA assembly functions as a transmembrane 
cation/proton antiporter, moving Ag+ from the cytoplasm directly to the cell exterior. It 
is classed as a member of the resistance, nodulation and cell division (RND) 




superfamily, sharing homologous sequences with similar resistance mechanisms in 
metal resistant Alcaligenes and multi-drug resistance mechanisms in E. coli [8990, 
9293, 9394]. 
 
Silver resistance has been found in clinical isolates of E. coli, Enterobacter cloacae, 
Proteus mirabilis and Klebsiella pneumoniae in a burns unit. In addition silver nitrate 
and SSD treatment has also been associated with resistance in Proteus spp., 
Enterobacter cloacae and miscellaneous Enterobacteriaceae [9495]. Similarly, 
resistance to multiple antibiotics and Ag+ has been shown in Salmonella species 
[9596]. Laboratory exposure of clinical strains of E. coli to stepwise increases of 
silver nitrate or SSD has been shown to induce cross-resistance against both 
compounds [9697].  
 
A sil E gene has been detected in MRSA strains, isolated from dogs, and is ≥95% 
homologous with the sil E from plasmid, pMG101 [9798]. However these isolates 
were still sensitive to treatment with silver impregnated hydrofibers. The results from 
this study are compatible with those of Silver, 2003 and suggest that there is low 
prevalence of silver resistance in MRSA [8990]. The restricted occurance of a single 
sil E gene encoding for resistance, is not sufficient to induce significant resistance 
against silver [97]. 
 
Toxicity concerns 
In common with many drug treatments, over exposure to the agents causes 
unwelcome side effects. Long term topical exposure to high concentrations of Ag+ 
leads to a build up of Ag0 in the dermis causing an irreversible blue-grey 
discolouration of the skin (argyria). This is particularly pronounced in areas exposed 
to sunlight which accelerates the photoreduction and deposition of  Ag0 [27, 70]. 
Some patients treated with silver containing-dressings reported the occurrence of 
skin rashes, stinging and burning sensations when treated with silver impregnated-




dressings [26]. Other more serious problems associated with topical application can 
include disturbances in electrolyte concentration resulting in hyponatremia or 
hypochloremia [80]. 
 
Despite the beneficial properties of various silver based treatments, the potential 
toxicity and safety issues of silver use have to be carefully considered. With the 
increased availability of formulations, administration of silver can be tailored to the 
patient’s condition, thus limiting the potential risk of side effects. 
 
Conclusion 
There has been increasing interest in the use of alternative, broad spectrum, pre-
antibiotic antimicrobial agents such as essential oils and metal ions to address 
issues relating to increased antibiotic resistant hospital infections. The versatility of 
alternative agents such as TTO and Ag+ against a wide range of different 
microorganisms due to their multiple target sites impedes the development of 
resistance and might be useful in improving the current wound treatment strategies. 
Despite the effectiveness of the agents, the potential development of side effects or 
toxicity to healthy host cells due to prolonged exposure at higher concentrations 
should be carefully monitored. Efforts to combine the use of these alternative 
antimicrobial agents with advances in targeted delivery techniques may help to 
address the issue of localized overloading and toxicity. Based on the current findings 
which showed the efficacy and beneficial therapeutic properties of both Ag+ and 
TTO, the potential advantages of using these agents in wound treatment regime 
should be explored further. 
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The use of broad spectrum, pre-antibiotic era antimicrobial agents, such as essential 
oils and metal ions, may be an alternative approach to tackling the growing problem 
of drug-resistant wound infections. The aim of this review is to consider the evidence 
for the use of silver and tea tree oil in tackling chronic wound infections such as 
those associated with diabetic foot and burns. The broad spectrum, multi-target 
mechanism of action of silver and tea tree oil indicate that there may be a role for 
them in a clinical setting to both reduce the microbial load within the wound bed and 
speed up the healing process. 
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Table 1: Summary of the major classes of active antimicrobial compounds from plants (summarized from references 24, 29, 39, 98, 
99, 100, 101) 
Class and description Subclass Example Mechanism Structure 
Phenolics 
 Simple phenolic ring structures which 
may exist in their highest oxidation state. 
E.g. cinnamic and caffeic acid which are 
phenylpropene derived compounds. 
 Number and site of hydroxyl group(s) 
present on the compound may indicate 
the relative toxicity to microorganisms. 
 Highly oxidised phenols or those with 
increased hydroxylation have increased 
microbial inhibitory effects.  











Quinone  Hypericin 
Binds to adhesins, 
complex with cell 
wall and inactivate 
enzyme  
Flavonoids Chrysin Binds to adhesins 
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viruses and fungi. 
 May cause iron deprivation, reaction 
with sulphydryl groups, protein related 
polyamide polymers via nonspecific 
interaction and hydrogen bonding to 


















metal ion  
complexation 
 





and has antiviral 
properties  
Terpenoids 
 Actively disrupts various membranes of 
bacteria, fungi, protozoa and enveloped 






 Secondary plant metabolites that have 




Intercalate into cell 
wall or DNA, 
differentially inhibit 
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aggregatory effects.  
Lectins and polypeptides 
 Inhibition of membrane function and 
integrity via interaction with proteins, ion 
channels and displacement of lipids.   
 Presence of cholesterol and increasing 
ionic strength in the target membrane 
reduces the antimicrobial activity due to 
stabilization of the lipid bilayer as well as 
the weakened electrostatic interaction to 
encourage binding to target membrane. 
NOTE: interaction with membrane 
peptides or  weakening of electrostatic 












between virus and 
host cell. May form 
ion channels in 
microbial 
membranes or 
reduce adhesion of 
microbial proteins 
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• Increases wound healing 
• Induces hypoglycemic 
effect 
• Lowers blood cholesterol 
• Used on burns and wounds. 
•  Treatment of psoriasis and 
genital herpes 





Arnica Arnica montana 
Sesquiterpene 
and lactones  
• Anti-inflammatory 
• Applied to bruises and swelling 













• Antimicrobial activity in food 
preservation and packaging 
industry 
108, 109 








• Anti-inflammatory  
• Anti-tumorogenic 
• Herbal antimicrobial mouthwash 
• Treatment against athletes foot, 









• Antiseptic  
• Inhibits biofilm formation by 
clinical strains of 
Staphylococcus epidermidis 







• Antibacterial  
• Antifungal 










• Insect repellent,  
• Skin penetration 
enhancer for drugs 
• Herbal antimicrobial mouthwash 
• Inhibits growth of food pathogen 
• Fragrant in pharmaceuticals, 
soaps, detergents and food 
117, 118, 
119, 120 
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• Natural pesticide/insecticide 
Garlic  Allium sativum Allicin 
• Antimicrobial 
• Potential anti-cancer 
agent 
• lowers cholesterol and 
triglycerides 
• In vitro antimicrobial activity 
against H. pylori 
• Food preservative   












• Reduces dental caries 















• In vitro  antimicrobial activity 
against H. pylori, E. coli, 
Mycobacterium tuberculosis, S. 
aureus and C. albicans 
• Treatment of asthma, cold, fever 
126, 127, 
128, 129 
Page 47 of 52 International Wound Journal
For Review Only







• Antimicrobial  
• Anti-inflammatory  
 
• Aids wound healing 
• Relieve fevers, inflammation 
and pain 
• Respiratory ailments 
23, 110 












Flavonoids,   
aspalathin,  
isoorientin,  
orientin and  
rutin 
• Antimicrobial  
• Antioxidant activity 
• In vitro antimicrobial and 
antifungal activity against 
Bacillus cereus, Micrococcus 
luteus and Candida albicans,  










• Antimicrobial  
• Antioxidant 
• In vitro antifungal activity 








• Anti-cellulitis (Pityrosporum) spp.,  











• Treatment of wounds 
• Pharmaceutical cosmetics and 
cleaning product applications 
32, 33, 110 
 




Table 3: Examples of heavy metals with antimicrobial properties  
Metal 
cations 









Membrane-bound copper ions may undergo Cu(I) to 
Cu(II) redox cycle catalyzing formation of highly toxic 





Competes with zinc for the active site of urease, thus 
inhibiting growth of Helicobacter pylori. 
142 
Silver, Ag+ 
Interacts with intracellular components to suppress 
expression of enzymes and proteins essential for 




Inhibits nutrient uptake, acid production and 
glycolysis in oral pathogens and rhinoviral replication. 








Table 4: Applications of heavy metals with lower toxicity to human cells  
Heavy metal 
ions 
Antimicrobial mechanism and uses  References 
Copper, 
Cu2+ 
• Inhibition of bacterial growth or bactericidal activity 
at 50-250 ppm. 
• Substitutes essential ions, blocks protein functional 
groups, inactivates enzymes, weakens membrane 
integrity and produces hydrogen peroxide free 
radicals when membrane bound. 
• E.g. antimicrobial hand rub, coated contact 
surfaces (copper toilet seats, brass taps, door 
handles, door push plates) and cleaning materials 





• Microbiocidal activity at 0.05 ppm in phosphate-
buffered saline or at >50–60.5 ppm in complex 
biological fluids. 
• Interact strongly with thiol groups, inhibits bacterial 
enzymes, interferes with electron transport, binds 
to DNA, thus inhibiting normal cell replication. 
• Formulated as creams and incorporated into 
dressings for the treatment of burns and wound 
infections. Also incorporated into polyalkenoate 
dental cements, textiles, water filters, kitchen 
appliances and medical devices (catheters).  
5, 28, 65, 
149, 150 
Zinc, Zn2+ • Inhibits replication of rhinovirus at <0.1mmol/L 65, 143, 
144, 149, 




(equivalent to <6.539 ppm). At 0.01-0.1mM 
(equivalent to 0.6539-6.539 ppm) inhibits acid 
production by oral plaque bacteria, effective 
against plaque and gingivitis when combined with 
trichlosan. Inhibits nutrient uptake, proton transfer 
and sugar transport. 
• Incorporated into polyalkenoate dental cements, 
stainless steel surface coatings, air conditioning 
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